![](https://endpts.com/wp-content/uploads/2024/05/Alex-Mayweg-and-Philip-Just-Larsen.jpg)
SixPeaks Bio' chair Alex Mayweg (L) and CEO Philip Just Larsen
Versant has a new obesity biotech. AstraZeneca has the option to buy it
AstraZeneca is stepping further into the obesity field with an option for a fledgling startup that seeks to preserve muscle mass, a common concern for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.